NURS 220: Anti-inflammatory RX Review
Inflammation Overview
Inflammation occurs with any type of cell injury, serving to destroy, dilute, or wall off (sequester) both the injurious agent and the injured tissue.
It is mediated by endogenous compounds, including:
Proteins of the complement system
Histamine
Serotonin
Bradykinin
Leukotrienes
Prostaglandins
Arachidonic Acid Pathway
Arachidonic acid is oxygenated and transformed into various products that mediate or modulate inflammatory reactions via two primary pathways:
Leukotriene pathway (Lipoxygenase):
Leads to vasoconstriction and increased vascular permeability, contributing to inflammation.
Prostaglandin pathway (Cyclooxygenase, COX-1 & COX-2):
COX-1: maintains gi mucosam as well as inflamatory repsonse
COX-2 Primary role is inflamation repsonse
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Definition: A large and chemically diverse group of drugs.
Mechanisms of Action:
Inhibition of the leukotriene pathway, prostaglandin pathway, or both.
Blocking the chemical activity of the cyclooxygenase (COX) enzyme.
Types of NSAIDs (by COX Selectivity):
Non-selective COX Inhibitors: Inhibit both COX-1 and COX-2 enzymes. They offer anti-inflammatory, analgesic, and antipyretic effects but also carry GI and renal side effects due to COX-1 inhibition. Examples include Ibuprofen, Naproxen, and traditional aspirin doses.
COX-2 Selective Inhibitors: Primarily inhibit COX-2, minimizing GI side effects by largely sparing COX-1. While effective for inflammation and pain, they are associated with an increased risk of cardiovascular thrombotic events due to an imbalance between PGI2 TXA2. Celecoxib is a prime example.
Therapeutic Effects:
Analgesic (pain relief)
nti-inflammatory
Antipyretic (fever reduction)
Platelet inhibition
NSAID Side Effects and Underlying Mechanisms
NSAIDs exert side effects primarily through COX inhibition, impacting various physiological systems:
Gastrointestinal (GI) Effects (linked to COX-1 inhibition):
COX-1 is responsible for producing (prostaglandin E2) which promotes gastric protection by increasing mucus secretion, bicarbonate production, and mucosal blood flow.
Inhibition of COX-1 by NSAIDs reduces these protective factors, leading to:
Peptic ulcers
GI bleeding
Renal Effects (linked to COX-1 and COX-2 inhibition):
and (prostacyclin) cause afferent arteriolar vasodilation, maintaining glomerular filtration rate (GFR).
These prostaglandins also promote sodium and water excretion.
COX inhibition by NSAIDs leads to:
Sodium and water retention
Hypertension
Hemodynamic acute kidney injury (e.g., reductions in creatinine clearance, acute tubular necrosis).
Cardiovascular Effects (linked to COX-1 and COX-2 inhibition):
Vascular (COX-2: ) promotes vasodilation and inhibits platelet aggregation.
Platelet (COX-1: - thromboxane) promotes vasoconstriction and platelet aggregation.
Differential inhibition can lead to imbalances:
COX-2 selective inhibitors might reduce without affecting , potentially increasing risk of thrombotic events.
COX-1 inhibition (like with aspirin) inhibits , preventing platelet aggregation.
Overall, NSAID use (except aspirin) has a Black Box Warning for increased risk of adverse cardiovascular thrombotic events, including fatal myocardial infarction (MI) and stroke.
NSAIDs may counteract the cardioprotective effects of aspirin.
Chemical Categories of NSAIDs
Salicylates: Aspirin, Arthropan
Acetic acid derivatives: Indocin (Indomethacin), Voltaren (Diclofenac), Toradol (Ketorolac)
Cyclooxygenase-2 (COX-2) inhibitors: Celebrex (Celecoxib)
Propionic acid derivatives: Ibuprofen (Motrin, Advil), Naproxen (Aleve)
Enolic acid derivatives: Relafen (Nabumetone), Mobic (Meloxicam), Feldene (Piroxicam)
Specific NSAIDs and Related Information
Salicylates: Aspirin (ASA)
Most common salicylate.
Actions:
Inhibits synthesis of prostaglandin, reducing pain and fever.
Inhibitor of COX-1 receptors within platelets, inhibiting platelet aggregation (antithrombotic effect).
Pharmacokinetics:
Metabolized in the liver, excreted in the urine.
Peak effect in minutes.
Formulations: Oral (PO), Topical, Per Rectal (PR) suppositories.
Dosing:
Maximum: mg/day.
Pain/fever: mg every hours.
Antithrombotic: Varies (e.g., mg PO chewed at the first sign of MI).
Antithrombotic Use:
Used in the treatment of MI and other thromboembolic disorders.
Shown to reduce cardiac death after MI.
Should be administered at the first sign of MI.
If not given pre-hospital, it's one of the first drugs in the ED if no contraindications.
Contraindications:
Known allergy.
Bleeding abnormalities.
Impaired renal or hepatic function.
Avoid use in children and teenagers due to the risk of Reye’s Syndrome.
Salicylate Toxicity (Salicism)
Symptoms:
Increased heart rate.
Tinnitus, hearing loss, dimness of vision.
Headache, dizziness, mental confusion, drowsiness.
Nausea, vomiting, diarrhea.
Sweating, thirst.
Hyperventilation.
Hypo- or hyperglycemia.
Reye's Syndrome:
A serious and potentially fatal condition characterized by encephalopathy and liver damage.
High risk with aspirin use in children and teens, especially if recovering from viral illnesses (e.g., flu, chickenpox).
Acetic Acid Derivatives
Indomethacin (Indocin):
Analgesic, anti-inflammatory, antirheumatic, and antipyretic properties.
Uses: Rheumatoid arthritis (RA), osteoarthritis (OA), acute bursitis or tendonitis, ankylosing spondylitis, acute gouty arthritis, patent ductus arteriosus (PDA), and treatment of preterm labor.
Available in oral, rectal, and intravenous forms.
Ketorolac (Toradol):
Possesses some anti-inflammatory activity.
Used primarily for its powerful analgesic effects, comparable to narcotic drugs like morphine.
Indication: Short-term use (up to days) for moderate to severe acute pain.
Adverse effects: Renal impairment, edema, GI pain, dyspepsia, nausea.
COX-2 Inhibitors
Celecoxib (Celebrex):
Currently the first and only remaining COX-2 inhibitor.
Indications: OA, RA, acute pain symptoms, ankylosing spondylitis, and primary dysmenorrhea.
Adverse effects: Headache, sinus irritation, diarrhea, fatigue, dizziness, lower extremity edema, and hypertension.
Has little effect on platelet function.
Contraindication: Not to be used in patients with known sulfa allergy.
Propionic Acid Derivatives
Ibuprofen (Motrin, Advil):
Most commonly used NSAID.
Uses: Analgesic effects in the management of RA, OA, primary dysmenorrhea, gout, dental pain, musculoskeletal disorders, and antipyretic actions.
Naproxen (Aleve):
Second most commonly used NSAID.
Generally has a better adverse effect profile than ibuprofen.
Fewer drug interactions with ACE inhibitors (used for hypertension).
Enolic Acid Derivatives
Used to treat mild to moderate OA, RA, and gouty arthritis.
Examples: Piroxicam (Feldene), Meloxicam (Mobic), Nabumetone (Relafen).
Nabumetone is generally better tolerated gastrointestinally than some other NSAIDs.
General NSAID Contraindications and Black Box Warnings
Black Box Warning: All NSAIDs (except aspirin) carry a black box warning regarding an increased risk of adverse cardiovascular thrombotic events, including fatal MI and stroke.
NSAIDs may counteract the cardioprotective effects of aspirin.
Known drug allergy.
Patients with documented aspirin allergy must not receive NSAIDs.
Conditions that place the patient at risk for bleeding:
Vitamin K deficiency.
Peptic ulcer disease.
Liver dysfunction.
Pregnancy: Misoprostol (Cytotec), a synthetic prostaglandin used to reduce stomach ulcers caused by NSAIDs, is contraindicated in pregnancy as it may cause abortion, premature birth, or birth defects.
Other NSAID Adverse Effects (General)
GI: Dyspepsia, heartburn, epigastric distress, nausea, GI bleeding, mucosal lesions (erosions or ulcerations).
Management: Misoprostol (Cytotec) may be prescribed to high-risk patients to reduce these dangerous effects.
Renal: Reductions in creatinine clearance, acute tubular necrosis with renal failure.
Cardiovascular: Noncardiogenic pulmonary edema (swelling).
Other Systems: Altered hemostasis, hepatotoxicity, skin eruption, sensitivity reaction, tinnitus, hearing loss.
Nursing Implications for NSAIDs
Do not give salicylates to children and teenagers due to the risk of Reye’s syndrome.
NSAIDs generally cause GI distress; they are often better tolerated if taken with food, milk, or an antacid to avoid irritation.
Inform patients that therapeutic effects may not be seen for to weeks.
Educate patients about adverse effects and instruct them to notify prescribers if effects become severe or if bleeding or GI pain occurs.
Advise patients to watch closely for any unusual bleeding, such as in the stool.
Enteric-coated tablets should not be crushed or chewed.
Monitor for therapeutic effects, which vary depending on the condition being treated (e.g., decrease in swelling, pain, stiffness, and tenderness of a joint or muscle area).
NSAID Interactions
Serious interactions can occur when given with:
Anticoagulants (increased bleeding risk).
Aspirin (NSAIDs may reduce cardioprotective effects of aspirin).
Corticosteroids and other ulcerogenic drugs (increased GI ulceration/bleeding risk).
Protein-bound drugs (competition for binding sites, altered drug levels).
Diuretics and ACE inhibitors (reduced effectiveness of these drugs, increased risk of renal toxicity).
Norco vs. Vicodin and Acetaminophen
Both Norco and Vicodin are combination drugs containing hydrocodone and acetaminophen (APAP).
Vicodin: mg hydrocodone / mg APAP.
Norco: mg hydrocodone / mg APAP.
Norco has a higher proportion of hydrocodone to acetaminophen than Vicodin.
Acetaminophen:
Does not reduce inflammation.
Has no effect on platelets.
Provides only analgesic (pain relief) effects.
Mechanism of action is unknown; metabolized in the liver.